Evaluation of gefitinib alone or combined with bevacizumab in patients with EGFR L858R-positive advanced non-squamous non-small cell lung cancer: an open-label, randomized, phase 2 trial (BEVA-FLFX-001) with exploratory analysis of plasma biomarkers - Zhao, Xinmin; Wu, Xianghua; Wang, Huijie; Yu, Hui; Sun, Si; Hu, Zhihuang; Lin, Ying; Zhang, Yao; Yu, Bo; Wu, Zhenhua; Xiong, Kangli; Liu, Cuicui; et al. (Translational Lung Cancer Research; Vol 14, No 10 (October 31, 2025): Translational Lung Cancer Research, 2025)